The pandemic led to the rapid acceleration in the adoption of telehealth services. In February of this year, there were 38x more outpatient virtual visits compared to February of 2020. Now the landscape is poised to expand on the earliest iterations and specialized care is one of the primary avenues. Oshi Health is a virtual-first care platform targeted for those with gastrointestinal (GI) conditions. Users of the platform have access to a suite of professionals including licensed gastroenterologists, practitioners, mental health professionals, dieticians, and health coaches. Under the unified care plan, patients that require in-person services are connected with a network of pre-vetted providers. Those with newly diagnosed chronic conditions can work hand-in-hand with experts to understand the impact of triggering behaviors in real-time; something that’s just not possible when you need to schedule an appointment and see someone in person. Oshi works directly with employers and health plans to offer their services to employees and members, ultimately leading to long-term savings and improved patient outcomes. AlleyWatch caught up with Oshi Health CEO Sam Holliday to learn more about how Oshi is bringing much-needed care to those with GI conditions, the company’s strategic plans, latest round of funding from investors that include Flare Capital Partners, Bessemer Venture Partners, Frist Cressey Ventures, CVS Health Ventures, Takeda Digital Ventures, Jonathan Bush, Nat Turner, Zach Weinberg, Eric M. Stone, and Russell Glass.
The latest venture capital, seed, pre-seed, and angel deals for NYC startups for 10/13/2021 featuring funding details for Mulberry Technology, Yup, and much more.